CNS stimulating agent with antidepressant and antiparkinson properties. Prepn: H. G. Menge, J. Klosa, DE 1936452; eidem, US 4016280 (1971, 1977 both to Byk Gulden). Evaluation of MAO-inhibitory properties in vivo and in vitro: G. Planz et al., Arzneim.-Forsch. 23, 281 (1973). Effects on 5-hydroxytryptamine uptake in platelets: M. Eltze et al., ibid. 30, 1129 (1980). Comparative study of effects in Parkinson's disease: E. Gründig, F. Gerstenbrand, Wien. Klin. Wochenschr. 92, 868 (1980).
Antiparkinsonian.
Antiparkinsonian; Monoamine Oxidase Inhibitor